Advertisement
Advertisement

CHE

CHE logo

Chemed Corporation

447.68
USD
Sponsored
-5.72
-1.26%
Feb 06, 16:00 UTC -5
Closed
exchange

After-Market

453.00

+5.32
+1.19%

CHE Earnings Reports

Positive Surprise Ratio

CHE beat 26 of 39 last estimates.

67%

Next Report

Date of Next Report
Feb 25, 2026
Estimate for Q4 25 (Revenue/ EPS)
$665.68M
/
$7.13
Implied change from Q3 25 (Revenue/ EPS)
+6.53%
/
+35.29%
Implied change from Q4 24 (Revenue/ EPS)
+4.01%
/
+4.39%

Chemed Corporation earnings per share and revenue

On Oct 28, 2025, CHE reported earnings of 5.27 USD per share (EPS) for Q3 25, missing the estimate of 5.42 USD, resulting in a -2.88% surprise. Revenue reached 624.90 million, compared to an expected 632.29 million, with a -1.17% difference. The market reacted with a +6.06% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 5 analysts forecast an EPS of 7.13 USD, with revenue projected to reach 665.68 million USD, implying an increase of 35.29% EPS, and increase of 6.53% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
DaVita Inc.
Report Date
Feb 02, 2026 For Q4 25
Estimate
$3.18
Actual
$3.39
Surprise
+6.37%
logo
Encompass Health Corporation Common Stock
Report Date
Feb 05, 2026 For Q4 25
Estimate
$1.31
Actual
$1.46
Surprise
+11.35%
FAQ
For Q3 2025, Chemed Corporation reported EPS of $5.27, missing estimates by -2.88%, and revenue of $624.90M, -1.17% below expectations.
The stock price moved up 6.06%, changed from $438.94 before the earnings release to $465.54 the day after.
The next earning report is scheduled for Feb 25, 2026.
Based on 5 analysts, Chemed Corporation is expected to report EPS of $7.13 and revenue of $665.68M for Q4 2025.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement